View Discovery
Trials for Market Approval
Download PPTPre-Clinical (GLP)
Guangzhou Institute of Respiratory Medicine Company Limited, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
Phase 1
Bill & Melinda Gates Medical Research Institute, Merck & Co., Inc., NIAID, NIH, DHHS
GlaxoSmithKline, TB Drug Accelerator, Bill & Melinda Gates Foundation
TB Alliance, ERA4TB (European Regimen Accelerator for Tuberculosis), University of Auckland, Merck & Co., Inc.
Bill & Melinda Gates Medical Research Institute, Merck & Co., Inc.
iM4TB - Innovative Medicines for Tuberculosis, Bill & Melinda Gates Foundation
Phase 2
Otsuka Pharmaceutical Development & Commercialization, Inc.
GlaxoSmithKline, Bill & Melinda Gates Foundation
Sequella, Inc, TB Alliance
University of Munich, Hans-Knöll Institute, Jena, German Center for Infection Research (DZIF), European and Developing Countries Clinical Trials Partnership (EDCTP), Radboud University
PanACEA, EDCTP, NIAID, NIH, DHHS, USAID
TB Alliance
LegoChem Biosciences, Inc.
Qurient Co., Ltd, Qurient Co. Ltd. / LLC "Infectex", a portfolio firm of Maxwell Biotech Venture Fund
TB Alliance, Bill & Melinda Gates Medical Research Institute, Foundation for Neglected Disease Research
TB Alliance
Phase 3
Shanghai Jiatan Biotech Ltd., subsidiary of Guangzhou JOYO Pharma Ltd., Shanghai, China
Otsuka Pharmaceutical Development & Commercialization, Inc.